Intelligencer
The Cut
Vulture
The Strategist
Curbed
Grub Street
Magazine
Subscribe to the Magazine
Give a Gift Subscription
Buy Back Issues
Current Issue Contents
New York
Shop
Subscribe
Sign In
Account
Profile
Sign Out
Menu
Menu
Close
Close
Search
Intelligencer
Politics
Technology
Business
Ideas
The Cut
Style
Self
Culture
Power
The Cut Shop
Vulture
TV
Movies
Comedy
Music
Books
Art
Theater
What to Stream
Curbed
Cityscape
Design Hunting
The Real Estate
Best of New York
The Strategist
Gift Guides
Sales
Beauty
Home
Kitchen + Dining
Fashion
Travel
Tech & Electronics
Fitness
Kids & Babies
Grub Street
Restaurants & Bars
The Thousand Best
The Magazine
Crossword
Current Issue
Subscribe
Gift Subscriptions
Buy Back Issues
More
About
New York
Shop
Newsletters
Podcasts
Videos
Best Doctors
Top Rated Lawyers
Sign In
Subscribe
Search
Like Us
Follow Us
Follow
Search
Search
Close
Subscribe
Give A
Gift
Menu
Menu
Close
Close
Search
Intelligencer
Politics
Technology
Business
Ideas
The Cut
Style
Self
Culture
Power
The Cut Shop
Vulture
TV
Movies
Comedy
Music
Books
Art
Theater
What to Stream
Curbed
Cityscape
Design Hunting
The Real Estate
Best of New York
The Strategist
Gift Guides
Sales
Beauty
Home
Kitchen + Dining
Fashion
Travel
Tech & Electronics
Fitness
Kids & Babies
Grub Street
Restaurants & Bars
The Thousand Best
The Magazine
Crossword
Current Issue
Subscribe
Gift Subscriptions
Buy Back Issues
More
About
New York
Shop
Newsletters
Podcasts
Videos
Best Doctors
Top Rated Lawyers
Sign In
Subscribe
Search
Like Us
Follow Us
Follow
Search
Search
Close
Displaying all articles tagged:
Pharma
interesting times
May 10, 2019
Andrew Sullivan: Who Should Be Allowed to Compete in Women’s Sports?
The debate is legitimate and important. But some of the arguments being made in major publications are patently false.
By
Andrew Sullivan
innovation
Sept. 7, 2018
OxyContin Billionaire Patents New Drug for Opioid Treatment
Richard Sackler made billions convincing Americans that OxyContin wasn’t addictive. Now, he’s going to make millions selling them addiction treatment.
By
Eric Levitz
June 1, 2017
Tom Price Bought Pharma Stocks — Then Lobbied for the Industry in Australia
The Health secretary’s blatant corruption grows even more blatant.
By
Eric Levitz
Jan. 31, 2017
Trump Meets Big-Pharma CEOs, Then Seems to Flip-flop on Negotiating Drug Prices
On the campaign trail he mocked the lobbyists. Today he sounded like one.
By
Ed Kilgore
Jan. 12, 2017
Why Cory Booker’s Midnight Vote on Drug Importation Is Getting So Much Attention
To the alarm of progressives, he is apparently bending to the interests of wealthy donors even as he is rising to Democratic stardom.
By
Ed Kilgore
Jan. 11, 2017
Trump Tanks Pharma Stocks With Sudden Threat to Fight High Drug Prices
In his first press conference, he revived a nearly forgotten plan to authorize government negotiations on pharmaceutical prices.
By
Ed Kilgore